Testing effectiveness (Phase 2)Active Not RecruitingNCT03556332
What this trial is testing
Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 41